Viatris (VTRS) EBT (2019 - 2026)
Viatris (VTRS) posted EBT of -$64.0 million for Q2 2026, up 74.12% on a QoQ basis from -$247.3 million in Q1 2026, and up 70.52% year-over-year from -$37.5 million in Q2 2025.
Analysis
Viatris (VTRS) EBT (2019 - 2026) Analysis & Trends
Viatris has reported EBT for 8 years, with the latest figure at -$64.0 million in Q2 2026.
- On a quarterly basis, EBT rose 70.52% year-over-year to -$64.0 million in Q2 2026; TTM through Jun 2026 was -$662.2 million, a 82.34% increase from a year earlier, with the FY2025 full-year figure at -$3.7 billion, down 488.09% from the prior year.
- EBT was -$64.0 million for Q2 2026 at Viatris, up from -$247.3 million in the prior quarter.
- The five-year high for EBT was $1.5 billion in Q4 2022, with the low at -$3.1 billion in Q1 2025.
- Average EBT over 5 years is -$88.0 million, with a median of $41.3 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2025: EBT soared 820.4% in 2022, then sank 1613.69% in 2025.
- Over 5 years, EBT stood at $1.5 billion in 2022, then tumbled by 158.21% to -$855.0 million in 2023, then soared by 38.42% to -$526.5 million in 2024, then surged by 34.85% to -$343.0 million in 2025, then surged by 81.34% to -$64.0 million in 2026.
- The last three EBT figures came in at -$64.0 million (Q2 2026), -$247.3 million (Q1 2026), and -$343.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.61 Bn | 38.95 Bn | 2.15 Bn | -455.00 Mn |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn | -64.00 Mn |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | 58.37 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | 70.99 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 518.87 Mn | 2.10 Bn | 348.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -66.76 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 37.10 Mn |
| 8 | Amphastar Pharmaceuticals | 994.21 Mn | 704.09 Mn | 93.47 Mn | 38.54 Mn |
| 9 | Fennec Pharmaceuticals | 405.56 Mn | 364.31 Mn | 17.15 Mn | 2.02 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -64.00 Mn |
| Mar 31, 2026 | -247.30 Mn |
| Dec 31, 2025 | -343.00 Mn |
| Sep 30, 2025 | -7.90 Mn |
| Jun 30, 2025 | -217.10 Mn |
| Mar 31, 2025 | -3.10 Bn |
| Dec 31, 2024 | -526.50 Mn |
| Sep 30, 2024 | 90.50 Mn |
| Jun 30, 2024 | -391.80 Mn |
| Mar 31, 2024 | 204.60 Mn |
| Dec 31, 2023 | -855.00 Mn |
| Sep 30, 2023 | 402.20 Mn |
| Jun 30, 2023 | 333.00 Mn |
| Mar 31, 2023 | 322.70 Mn |
| Dec 31, 2022 | 1.47 Bn |
| Sep 30, 2022 | 427.50 Mn |
| Jun 30, 2022 | 389.30 Mn |
| Mar 31, 2022 | 527.50 Mn |
| Dec 31, 2021 | -203.90 Mn |
| Sep 30, 2021 | 199.90 Mn |